EUVIMEDScopri EUVIMED
Übersichtsarbeit

Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA

Hefen Chen iD, Zhujun Gong, Hong Zhou, Yong Han

Drug Development Research · 2024

DOI: 10.1002/ddr.22167 ↗

At a glance

Übersichtsarbeit in Drug Development Research, 2024. Written by Hefen Chen and 3 co-authors. Institution: Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Major MEDLINE topics: MicroRNAs, Osteosarcoma, Bone Neoplasms. Cited 8 times so far (Crossref); 154 references. Funded by: National Natural Science Foundation of China.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Osteosarcoma (OS) is a primary malignant bone tumor and is prevalent in children, adolescents, and elderly individuals. It has the characteristics of high invasion and metastasis. Neoadjuvant chemotherapy combined with surgical resection is the most commonly used treatment for OS. However, the efficacy of OS is considerably diminished by chemotherapy resistance. In recent years, noncoding RNAs (ncRNAs), including microRNAs, long noncoding RNAs, and circular RNAs, are hot topics in the field of chemotherapy resistance research. Several studies have demonstrated that ncRNAs are substantially associated with chemoresistance in OS. Thus, the present study overviews the abnormally expressed ncRNAs in OS and the molecular mechanisms involved in chemoresistance, with an emphasis on their function in promoting or inhibiting chemoresistance. ncRNAs are expected to become potential therapeutic targets for overcoming drug resistance and predictive biomarkers in OS, which are of great significance for enhancing the therapeutic effect and improving the prognosis.

Subjects

MeSH terms (MEDLINE)

MicroRNAsOsteosarcomaBone NeoplasmsAdolescentChildAgedHumansDrug Resistance, NeoplasmRNA, Untranslated

Author keywords

chemoresistancenoncoding RNAosteosarcoma

Substances

MicroRNAsRNA, Untranslated

Authors and institutions

  • Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Pharmacy, Chongqing Medical University, Chongqing, China.

ORCID profiles: Hefen Chen

Funding

  • National Natural Science Foundation of China

Cite

APA

Chen, H., Gong, Z., Zhou, H., & Han, Y. (2024). Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA. Drug Development Research. https://doi.org/10.1002/ddr.22167

Vancouver

Chen H, Gong Z, Zhou H, Han Y. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA. Drug Development Research. 2024. doi:10.1002/ddr.22167

BibTeX
@article{Chen2024,
  author = {Chen, Hefen and Gong, Zhujun and Zhou, Hong and Han, Yong},
  title = {Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA},
  journal = {Drug Development Research},
  year = {2024},
  doi = {10.1002/ddr.22167}
}
Start for free →